Mapping research performance and hotspots on nanoparticles in cardiovascular diseases

Dan Yin1,2,3,4,5, Mi Li2,3,4,5, Ping Xiang2,3,4,5

  • 1Department of Ultrasound, Children's Hospital of Chongqing Medical University, Chongqing, China.

Medicine
|April 14, 2023
PubMed
Summary

Nanoparticles show significant potential in cardiovascular disease research, with global publications steadily increasing. China and the US lead in this field, focusing on targeted drug delivery, myocardial infarction, and atherosclerosis.